Live from the NIH registry
Studies recruiting near Hagerstown right now
Top 25 of 114 recruiting studies, sorted by proximity — each links to its official registry page
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Frederick Oncology Hematology Associates — Frederick, Maryland (22.8 mi)
· Sponsor: City of Hope Medical Center
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Ability x Ottobock.care — Frederick, Maryland (22.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 700 participants sought
James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Eli Lilly and Company
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
Cumberland Valley Retina Consultants (CVRC) — Hagerstown, Maryland (0.1 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Klein And Associates M D P A — Hagerstown, Maryland (0.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Klein & Associates, M.D., P.A. — Hagerstown, Maryland (0.1 mi)
· Sponsor: Eli Lilly and Company
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 197 — Hagerstown, Maryland (0.1 mi)
· Sponsor: Adverum Biotechnologies, Inc.
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Diabetic Macular Edema (DME)
Phase 3
Interventional 910 participants sought
Kodiak Research Center — Hagerstown, Maryland (0.1 mi)
· Sponsor: Kodiak Sciences Inc
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
Wound Heal, Ulcer
N/A
Interventional 235 participants sought
US-FAS — Hagerstown, Maryland (0.1 mi)
· Sponsor: ConvaTec Inc.
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Mid Atlantic Retina Specialists — Hagerstown, Maryland (0.1 mi)
· Sponsor: EyeBiotech Ltd.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: SWOG Cancer Research Network
Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
HIV Testing, HEPATITIS C (HCV)
N/A
Observational 200 participants sought
WVU Department of Family Medicine - Eastern Division — Harpers Ferry, West Virginia (21.8 mi)
· Sponsor: West Virginia University
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: NRG Oncology
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Klein and Associates — Hagerstown, Maryland (0.1 mi)
· Sponsor: Novartis Pharmaceuticals
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
N/A
Observational 1,018 participants sought
Frederick Memorial Hospital — Frederick, Maryland (22.8 mi)
· Sponsor: Zeenat Qureshi Stroke Institute
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Frederick Oncology Hematology Associates — Frederick, Maryland (22.8 mi)
· Sponsor: Agendia
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Gettysburg, Pennsylvania (29.2 mi)
· Sponsor: AstraZeneca